highperformr logo

Northwest Biotherapeutics's Overview

Total employees17
HeadquartersBethesda
Founded1998

Northwest Biotherapeutics, Inc. (NWBO) is a clinical-stage biotechnology company focused on developing personalized immune therapies for cancer. Their lead product platform, DCVax®, utilizes the patient's own dendritic cells, a type of immune cell, to mobilize the entire immune system to attack cancer. The company is primarily advancing DCVax-L for glioblastoma multiforme (GBM), the most aggressive and lethal form of brain cancer, and DCVax-Direct for all types_of inoperable solid tumors. Their approach aims to create tailored treatments with potentially fewer side effects than conventional therapies.

Where is Northwest Biotherapeutics's Headquarters?

HQ Function

Serves as the central hub for corporate administration, strategic planning, clinical trial oversight, regulatory affairs, and investor relations.

Notable Features:

The headquarters is situated in a modern office building, providing a professional environment conducive to managing complex biotechnology operations and research collaborations.

Work Culture:

The work culture is likely intensive and mission-driven, characterized by scientific rigor, a focus on innovation in cancer treatment, and collaboration among a relatively small, specialized team.

HQ Significance:

Its location in Bethesda provides strategic advantages, including proximity to key regulatory bodies, research institutions, and a skilled talent pool in the biotech sector.

Values Reflected in HQ: The headquarters' location and function reflect a commitment to scientific advancement, regulatory compliance, and strategic engagement within the U.S. biomedical ecosystem.

Location:

Northwest Biotherapeutics supports its global clinical trial programs and prepares for potential commercialization primarily through its headquarters in the US (Maryland) and key manufacturing and operational facilities in the United Kingdom and Belgium. These locations enable research, development, manufacturing, and regulatory interactions across North America and Europe, which are the main regions for its ongoing and planned clinical studies for DCVax therapies.

Street Address:

4800 Montgomery Lane, Suite 800

City:

Bethesda

State/Province:

Maryland

Country:

USA

Northwest Biotherapeutics's Global Presence

Sawston, Cambridgeshire, UK

Address: Sawston Trade Park, London Road, Sawston, Cambridge, CB22 3EE, UK

Supports clinical development and future commercial manufacturing for the UK and European markets, ensuring compliance with MHRA (UK) and potentially EMA (EU) regulatory requirements.

Heist-op-den-Berg, Belgium

Address: Industriepark B7, 2220 Heist-op-den-Berg, Belgium

Enhances manufacturing capacity and logistical reach within continental Europe, supporting clinical trials and preparing for broader market access.

Buying Intent Signals for Northwest Biotherapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Northwest Biotherapeutics

As of April 2025, Northwest Biotherapeutics' leadership includes:

Linda F. Powers - Chairman & Chief Executive Officer
Dr. Alton L. Boynton - Chief Scientific Officer & President
Marnix L. Bosch - Chief Technical Officer

Investors of Northwest Biotherapeutics

Northwest Biotherapeutics has been backed by several prominent investors over the years, including:

Toucan Capital Corp (significant historical investor, often affiliated with Linda Powers)
Various institutional investors (e.g., BlackRock, Vanguard - typical for publicly traded companies, though individual % may vary)
Retail investors (as a publicly traded company on OTCQB: NWBO)

Executive New Hires/Exits in the Last 12 Months

Hire0
Exits0

Northwest Biotherapeutics has a relatively small and stable core executive team. Publicly available information and press releases over the last 12-18 months do not indicate significant high-profile executive hires or departures. Leadership continuity appears to be a feature.

Technology (Tech Stack) used by Northwest Biotherapeutics

Discover the tools Northwest Biotherapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Northwest Biotherapeutics Email Formats and Examples

Northwest Biotherapeutics likely uses common corporate email formats. The most probable format is first initial followed by last name.

[first_initial][last]@nwbio.com

Format

lpowers@nwbio.com

Example

80%

Success rate

News and media

GlobeNewswireMarch 7, 2024

Northwest Biotherapeutics News: NW Bio Provides Update on Regulatory Submissions in Process

Northwest Biotherapeutics announced progress on its Marketing Authorization Application (MAA) to the MHRA in the UK and its New Drug Application (NDA) to the FDA in the US for DCVax-L for Glioblastoma. The company is actively addressing queries from regulatory agencies....more

GlobeNewswireOctober 26, 2023

Northwest Biotherapeutics News: NW Bio Achieves Key MHRA Certifications for Sawston, UK Manufacturing Facility

Northwest Biotherapeutics announced that its Sawston, UK manufacturing facility received crucial certifications from the Medicines and Healthcare products Regulatory Agency (MHRA), including Good Manufacturing Practice (GMP) certification and Manufacturer's Importation Authorisation (MIA)....more

JAMA OncologyNovember 10, 2022

Northwest Biotherapeutics News: Phase 3 Trial Data for DCVax-L Published in JAMA Oncology

The results of the Phase 3 clinical trial of DCVax-L for newly diagnosed and recurrent glioblastoma (GBM) were published in JAMA Oncology, showing extended survival in certain patient populations. This publication was a significant milestone for the company....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Northwest Biotherapeutics, are just a search away.